Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism


Author index

Page Path
Henrik Falhammar 1 Article
Adrenal Gland
Long-Term Outcomes of Congenital Adrenal Hyperplasia
Anna Nordenström, Svetlana Lajic, Henrik Falhammar
Endocrinol Metab. 2022;37(4):587-598.   Published online July 8, 2022
  • 29,073 View
  • 231 Download
  • 11 Citations
AbstractAbstract PDFPubReader   ePub   
A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.


Citations to this article as recorded by  
  • Congenital adrenal hyperplasia: New biomarkers and adult treatments
    Bleuenn Dreves, Yves Reznik, Antoine Tabarin
    Annales d'Endocrinologie.2023; 84(4): 472.     CrossRef
  • Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
    Kyriakie Sarafoglou, Deborah P Merke, Nicole Reisch, Hedi Claahsen-van der Grinten, Henrik Falhammar, Richard J Auchus
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(9): 2154.     CrossRef
  • Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)
    Heike Hoyer-Kuhn, Alexander J Eckert, Gerhard Binder, Walter Bonfig, Angelika Dübbers, Stefan Riedl, Joachim Woelfle, Helmuth G Dörr, Reinhard W Holl
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): e1199.     CrossRef
  • Specialty grand challenge in adrenal endocrinology
    Henrik Falhammar
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Contexts of care for people with differences of sex development
    Alexandra E. Kulle, Martina Jürgensen, Ulla Döhnert, Lisa Malich, Louise Marshall, Olaf Hiort
    Medizinische Genetik.2023; 35(3): 181.     CrossRef
  • Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia
    Tania M. Espinosa Reyes, Alba Katherine Pesántez Velepucha, Julio Oscar Cabrera Rego, Wendy Valdés Gómez, Emma Domínguez Alonso, Henrik Falhammar
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Increased Prevalence of Accidents and Injuries in Congenital Adrenal Hyperplasia: A Population-based Cohort Study
    Henrik Falhammar, Angelica Lindén Hirschberg, Agneta Nordenskjöld, Henrik Larsson, Anna Nordenström
    The Journal of Clinical Endocrinology & Metabolism.2023;[Epub]     CrossRef
  • Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
    Mara Carsote, Ana-Maria Gheorghe, Claudiu Nistor, Alexandra-Ioana Trandafir, Oana-Claudia Sima, Anca-Pati Cucu, Adrian Ciuche, Eugenia Petrova, Adina Ghemigian
    Biomedicines.2023; 11(11): 3081.     CrossRef
  • Editorial: Recent advances in diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Semra Çaglar Çetinkaya
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Approach of Heterogeneous Spectrum Involving 3beta-Hydroxysteroid Dehydrogenase 2 Deficiency
    Andreea Gabriela Nicola, Mara Carsote, Ana-Maria Gheorghe, Eugenia Petrova, Alexandru Dan Popescu, Adela Nicoleta Staicu, Mihaela Jana Țuculină, Cristian Petcu, Ionela Teodora Dascălu, Tiberiu Tircă
    Diagnostics.2022; 12(9): 2168.     CrossRef
  • Effetti di Crinecerfont sulla secrezione di ACTH nell’iperplasia surrenalica congenita: uno studio di fase 2
    Marianna Rita Stancampiano, Silvia Laura Carla Meroni, Giovanna Weber, Gianni Russo
    L'Endocrinologo.2022; 23(6): 662.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism